{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:58:21Z","timestamp":1785527901412,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"October University for Modern Sciences and Arts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A stepwise optimization guidance model for rapid multi-analyte UPLC\u2013MS\/MS is proposed to report recurring limitations in bioanalytical method development. The model involves six stages: (1) physicochemical profiling, (2) extraction strategy selection, (3) chromatographic optimization, (4) mobile phase selection, (5) method validation, and (6) greenness evaluation. The applicability of this framework was demonstrated by determining Rifaximin, Ciprofloxacin, and Fluconazole in spiked human plasma, using Ibuprofen as an internal standard. Physicochemical profiling guided the selection of ionization mode and prediction of solubility behavior. Based on the model recommendations, liquid\u2013liquid extraction using dichloromethane was selected to achieve effective analyte recovery. Chromatographic optimization and mobile phase selection through the proposed framework supported the use of rapid isocratic separation on a C18 column using a methanol\/water mixture (95:5, v\/v) as mobile phase. The method validation, performed as an integral stage of the workflow according to regulatory guidelines, demonstrated exceptional linearity (r\u00b2 \u2265 0.999). The final stage of the model involved evaluating environmental applicability using AGSA and EPPI analyses. The proposed sequential framework is intended to serve as a methodological reference for analysts employing LC\u2013MS\/MS platforms, to establish a structured and reproducible analytical workflow that advances ecological sustainability in multi-analyte LC\u2013MS\/MS bioanalytical applications.<\/jats:p>","DOI":"10.1038\/s41598-026-63587-9","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:24:53Z","timestamp":1785273893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A systematic stepwise optimization framework for rapid multi-analyte UPLC\u2013MS\/MS plasma analysis with integrated sustainability assessment"],"prefix":"10.1038","volume":"16","author":[{"given":"Amira E.","family":"Abd-Elnabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr M.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina A.","family":"El Mously","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omnia A.","family":"El-Naem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"63587_CR1","doi-asserted-by":"publisher","first-page":"114790","DOI":"10.1016\/j.biopha.2023.114790","volume":"163","author":"J Mula","year":"2023","unstructured":"Mula, J. et al. Analytical validation of a novel UHPLC-MS\/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS\/MS Kit. Biomed. Pharmacother. 163, 114790. https:\/\/doi.org\/10.1016\/j.biopha.2023.114790 (2023).\u00a0","journal-title":"Biomed. Pharmacother."},{"key":"63587_CR2","doi-asserted-by":"publisher","first-page":"115886","DOI":"10.1016\/j.trac.2020.115886","volume":"127","author":"X Wei","year":"2020","unstructured":"Wei, X. et al. Recent advances in single-cell ultra-trace analysis. TRAC Trends Anal. Chem. 127, 115886. https:\/\/doi.org\/10.1016\/j.trac.2020.115886 (2020).","journal-title":"TRAC Trends Anal. Chem."},{"issue":"4","key":"63587_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/jac\/dkae047","volume":"79","author":"XM Mekking","year":"2024","unstructured":"Mekking, X. M. et al. Development and validation of an UPLC\u2013MS\/MS assay for the simultaneous quantification of seven commonly used antibiotics in human plasma and its application in therapeutic drug monitoring. J. Antimicrob. Chemother. 79 (4), 883\u2013890. https:\/\/doi.org\/10.1093\/jac\/dkae047 (2024).","journal-title":"J. Antimicrob. Chemother."},{"key":"63587_CR4","doi-asserted-by":"publisher","first-page":"114904","DOI":"10.1016\/j.jpba.2022.114904","volume":"219","author":"S Bahmany","year":"2022","unstructured":"Bahmany, S. et al. High-throughput analysis for the simultaneous quantification of nine beta-lactam antibiotics in human plasma by UPC2-MS\/MS: Method development, validation, and clinical application. J. Pharm. Biomed. Anal. 219, 114904. https:\/\/doi.org\/10.1016\/j.jpba.2022.114904 (2022).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"63587_CR5","doi-asserted-by":"publisher","unstructured":"El Deeb, S. Enhancing sustainable analytical chemistry in liquid chromatography: guideline for transferring classical high-performance liquid chromatography and ultra-high-pressure liquid chromatography methods into Greener, Bluer, and Whiter Methods. Molecules 29 https:\/\/doi.org\/10.3390\/molecules29133205 (2024).","DOI":"10.3390\/molecules29133205"},{"issue":"1","key":"63587_CR6","doi-asserted-by":"publisher","first-page":"19138","DOI":"10.1038\/s41598-022-22998-0","volume":"12","author":"SK Muchakayala","year":"2022","unstructured":"Muchakayala, S. K. et al. AQbD based green UPLC method to determine mycophenolate mofetil impurities and Identification of degradation products by QToF LCMS. Sci. Rep. 12 (1), 19138. https:\/\/doi.org\/10.1038\/s41598-022-22998-0 (2022).","journal-title":"Sci. Rep."},{"issue":"9","key":"63587_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/ja.2014.106","volume":"67","author":"F Calanni","year":"2014","unstructured":"Calanni, F. et al. Rifaximin: beyond the traditional antibiotic activity. J. Antibiot. (Tokyo). 67 (9), 667\u2013670. https:\/\/doi.org\/10.1038\/ja.2014.106 (2014).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"63587_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ejmech.2018.01.078","volume":"146","author":"GF Zhang","year":"2018","unstructured":"Zhang, G. F. et al. Ciprofloxacin derivatives and their antibacterial activities. Eur. J. Med. Chem. 146, 599\u2013612. https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.078 (2018).","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"63587_CR9","first-page":"227","volume":"72","author":"Z Safaei","year":"2015","unstructured":"Safaei, Z. et al. Acta Pol. Pharm., 72(2): 227\u2013233 (2015).","journal-title":"Acta Pol. Pharm."},{"key":"63587_CR10","doi-asserted-by":"publisher","unstructured":"Soliman, N. et al. Small intestinal bacterial and fungal overgrowth: health implications and management perspectives. Nutrients 17 (8). https:\/\/doi.org\/10.3390\/nu17081365 (2025).","DOI":"10.3390\/nu17081365"},{"issue":"3","key":"63587_CR11","doi-asserted-by":"publisher","first-page":"103390microorga","DOI":"10.3390\/microorganisms11030573","volume":"11","author":"M Banaszak","year":"2023","unstructured":"Banaszak, M. et al. Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO. Microorganisms 11 (3), 103390microorganisms11030573\u2013103390microorganisms11030573 (2023).","journal-title":"Microorganisms"},{"key":"63587_CR12","doi-asserted-by":"publisher","unstructured":"Liu, A. et al. Gut Non-Bacterial microbiota: Emerging link to irritable bowel syndrome. Toxins (Basel). 14 (9). https:\/\/doi.org\/10.3390\/toxins14090596 (2022).","DOI":"10.3390\/toxins14090596"},{"key":"63587_CR13","doi-asserted-by":"publisher","unstructured":"Weekly, A. R. 1739(1): p. 32 - https:\/\/doi.org\/10.1007\/s40278-019-57672-6 (2019).","DOI":"10.1007\/s40278-019-57672-6"},{"issue":"13","key":"63587_CR14","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1021\/ac020361s","volume":"75","author":"BK Matuszewski","year":"2003","unstructured":"Matuszewski, B. K., Constanzer, M. L. & Chavez-Eng, C. M. Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC\u2009\u2013\u2009MS\/MS. Anal. Chem. 75 (13), 3019\u20133030. https:\/\/doi.org\/10.1021\/ac020361s (2003).","journal-title":"Anal. Chem."},{"issue":"1\u20132","key":"63587_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jchromb.2007.03.017","volume":"853","author":"G Hendriks","year":"2007","unstructured":"Hendriks, G., Uges, D. R. & Franke, J. P. Reconsideration of sample pH adjustment in bioanalytical liquid-liquid extraction of ionisable compounds. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 853 (1\u20132), 234\u2013241. https:\/\/doi.org\/10.1016\/j.jchromb.2007.03.017 (2007).","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"issue":"4","key":"63587_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jpba.2010.06.023","volume":"53","author":"S Lee","year":"2010","unstructured":"Lee, S. et al. Homogeneity and stability of a candidate certified reference material for the determination of methamphetamine and amphetamine in hair. J. Pharm. Biomed. Anal. 53 (4), 1037\u20131041. https:\/\/doi.org\/10.1016\/j.jpba.2010.06.023 (2010).","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1\u20132","key":"63587_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jchromb.2006.12.030","volume":"852","author":"E Chambers","year":"2007","unstructured":"Chambers, E. et al. Systematic and comprehensive strategy for reducing matrix effects in LC\/MS\/MS analyses. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 852 (1\u20132), 22\u201334. https:\/\/doi.org\/10.1016\/j.jchromb.2006.12.030 (2007).","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"issue":"1","key":"63587_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.aca.2009.10.004","volume":"656","author":"L Nov\u00e1kov\u00e1","year":"2009","unstructured":"Nov\u00e1kov\u00e1, L. & Vl\u010dkov\u00e1, H. A review of current trends and advances in modern bio-analytical methods: Chromatography and sample preparation. Anal. Chim. Acta. 656 (1), 8\u201335. https:\/\/doi.org\/10.1016\/j.aca.2009.10.004 (2009).","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"63587_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jchromb.2006.12.030","volume":"852","author":"E Chambers","year":"2007","unstructured":"Chambers, E. et al. Systematic and comprehensive strategy for reducing matrix effects in LC\/MS\/MS analyses. J. Chromatogr. B. 852 (1), 22\u201334. https:\/\/doi.org\/10.1016\/j.jchromb.2006.12.030 (2007).","journal-title":"J. Chromatogr. B"},{"key":"63587_CR20","unstructured":"Wells, D. High Throughput bioanalytical sample preparation: Methods and automation strategies. Prog. Pharm. Biomed. Anal. (2003)."},{"issue":"1\u20132","key":"63587_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/bmc.1568","volume":"25","author":"CF Chien","year":"2011","unstructured":"Chien, C. F., Wu, Y. T. & Tsai, T. H. Biological analysis of herbal medicines used for the treatment of liver diseases. Biomed. Chromatogr. 25 (1\u20132), 21\u201338. https:\/\/doi.org\/10.1002\/bmc.1568 (2011).","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"63587_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jchromb.2005.11.042","volume":"831","author":"MH Gschwend","year":"2006","unstructured":"Gschwend, M. H. et al. Selective and sensitive determination of amisulpride in human plasma by liquid chromatography\u2013tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring. J. Chromatogr. B. 831 (1), 132\u2013139. https:\/\/doi.org\/10.1016\/j.jchromb.2005.11.042 (2006).","journal-title":"J. Chromatogr. B"},{"key":"63587_CR23","doi-asserted-by":"publisher","unstructured":"Gavage, M., Delahaut, P. & Gillard, N. Suitability of high-resolution mass spectrometry for routine analysis of small molecules in food, feed and water for safety and authenticity purposes: A review. Foods 10 (3). https:\/\/doi.org\/10.3390\/foods10030601 (2021).","DOI":"10.3390\/foods10030601"},{"issue":"7","key":"63587_CR24","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1373\/49.7.1041","volume":"49","author":"TM Annesley","year":"2003","unstructured":"Annesley, T. M. Ion Suppression in Mass Spectrometry. Clin. Chem. 49 (7), 1041. https:\/\/doi.org\/10.1373\/49.7.1041 (2003).","journal-title":"Clin. Chem."},{"issue":"9","key":"63587_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.clinbiochem.2008.02.017","volume":"41","author":"M Vogeser","year":"2008","unstructured":"Vogeser, M. & Seger, C. A decade of HPLC\u2013MS\/MS in the routine clinical laboratory \u2014 Goals for further developments. Clin. Biochem. 41 (9), 649\u2013662. https:\/\/doi.org\/10.1016\/j.clinbiochem.2008.02.017 (2008).","journal-title":"Clin. Biochem."},{"key":"63587_CR26","doi-asserted-by":"publisher","first-page":"341573","DOI":"10.1016\/j.aca.2023.341573","volume":"1274","author":"A Souihi","year":"2023","unstructured":"Souihi, A. et al. Mobile phase and column chemistry selection for high sensitivity non-targeted LC\/ESI\/HRMS screening of water. Anal. Chim. Acta. 1274, 341573. https:\/\/doi.org\/10.1016\/j.aca.2023.341573 (2023).","journal-title":"Anal. Chim. Acta"},{"key":"63587_CR27","doi-asserted-by":"publisher","first-page":"463966","DOI":"10.1016\/j.chroma.2023.463966","volume":"1696","author":"A Brookhart","year":"2023","unstructured":"Brookhart, A. et al. Understanding mobile phase buffer composition and chemical structure effects on electrospray ionization mass spectrometry response. J. Chromatogr. A. 1696, 463966. https:\/\/doi.org\/10.1016\/j.chroma.2023.463966 (2023).","journal-title":"J. Chromatogr. A"},{"key":"63587_CR28","doi-asserted-by":"publisher","unstructured":"Larsen, C. et al. A tool for identifying green solvents for printed electronics. Nat. Commun. 12 (1). https:\/\/doi.org\/10.1038\/s41467-021-24761-x (2021).","DOI":"10.1038\/s41467-021-24761-x"},{"issue":"11","key":"63587_CR29","doi-asserted-by":"publisher","first-page":"2300111","DOI":"10.1002\/sscp.202300111","volume":"6","author":"P Prajapati","year":"2023","unstructured":"Prajapati, P. et al. Robust method operable design region for economical and eco-friendly chromatographic analysis of azilsartan medoxomil and cilnidipine by incorporating a hybrid approach of green analytical chemistry and analytical quality by design. Sep. Sci. PLUS. 6 (11), 2300111. https:\/\/doi.org\/10.1002\/sscp.202300111 (2023).","journal-title":"Sep. Sci. PLUS"},{"issue":"19","key":"63587_CR30","doi-asserted-by":"publisher","first-page":"2300332","DOI":"10.1002\/jssc.202300332","volume":"46","author":"P Prajapati","year":"2023","unstructured":"Prajapati, P. et al. Green analytical chemistry-driven response surface modeling to stability-indicating chromatographic method for estimation of cilnidipine and application of high-performance thin-layer chromatography\u2013mass spectrometry for characterization of degradation products. J. Sep. Sci. 46 (19), 2300332. https:\/\/doi.org\/10.1002\/jssc.202300332 (2023).","journal-title":"J. Sep. Sci."},{"issue":"19","key":"63587_CR31","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1039\/d4gc05298f","volume":"27","author":"PM Nowak","year":"2025","unstructured":"Nowak, P. M. et al. Red analytical performance index (RAPI) and software: the missing tool for assessing methods in terms of analytical performance. Green Chem. 27 (19), 5546\u20135553. https:\/\/doi.org\/10.1039\/d4gc05298f (2025).","journal-title":"Green Chem."},{"issue":"19","key":"63587_CR32","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/d3gc02347h","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi, N. et al. Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality. Green Chem. 25 (19), 7598\u20137604. https:\/\/doi.org\/10.1039\/d3gc02347h (2023).","journal-title":"Green Chem."},{"key":"63587_CR33","doi-asserted-by":"publisher","first-page":"102051","DOI":"10.1016\/j.scp.2025.102051","volume":"46","author":"FR Mansour","year":"2025","unstructured":"Mansour, F. R. et al. Analytical Green Star Area (AGSA) as a new tool to assess greenness of analytical methods. Sustainable Chem. Pharm. 46, 102051. https:\/\/doi.org\/10.1016\/j.scp.2025.102051 (2025).","journal-title":"Sustainable Chem. Pharm."},{"key":"63587_CR34","doi-asserted-by":"crossref","unstructured":"Mansour, F. R., P\u0142otka-Wasylka, J., Locatelli, M. & Modified, G. A. P. I. (eds) (MoGAPI) tool and software for the assessment of method greenness: Case studies and applications. Analytica 5(3), 451\u2013457 (2024).","DOI":"10.3390\/analytica5030030"},{"issue":"14","key":"63587_CR35","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira, F., Wojnowski, W. & Tobiszewski, M. AGREE\u2014Analytical GREEnness Metric Approach and Software. Anal. Chem. 92 (14), 10076\u201310082. https:\/\/doi.org\/10.1021\/acs.analchem.0c01887 (2020).","journal-title":"Anal. Chem."},{"key":"63587_CR36","doi-asserted-by":"publisher","unstructured":"Nowak, P. M., Wietecha-Pos\u0142uszny, R. & Pawliszyn, J. White analytical chemistry: An approach to reconcile the principles of Green Analytical Chemistry and functionality. TrAC Trends Anal. Chem. 138, 116223. https:\/\/doi.org\/10.1016\/j.trac.2021.116223 (2021).","DOI":"10.1016\/j.trac.2021.116223"},{"issue":"7","key":"63587_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/chromsci\/bmab044","volume":"59","author":"AC Kogawa","year":"2021","unstructured":"Kogawa, A. C. et al. Eco-friendly pharmaceutical analysis of rifaximin in tablets by HPLC-MS and microbiological turbidimetry. J. Chromatogr. Sci. 59 (7), 597\u2013605. https:\/\/doi.org\/10.1093\/chromsci\/bmab044 (2021).","journal-title":"J. Chromatogr. Sci."},{"key":"63587_CR38","doi-asserted-by":"publisher","first-page":"118444","DOI":"10.1016\/j.mseb.2025.118444","volume":"320","author":"VN Vu","year":"2025","unstructured":"Vu, V. N. et al. Enhanced photocatalytic degradation efficiency of ciprofloxacin in aquatic media by hydrotalcile materials modified by Cu2\u2009+\u2009and Co2\u2009+\u2009ions under LED light irradiation. Mater. Sci. Engineering: B. 320, 118444. https:\/\/doi.org\/10.1016\/j.mseb.2025.118444 (2025).","journal-title":"Mater. Sci. Engineering: B"},{"key":"63587_CR39","doi-asserted-by":"publisher","first-page":"102972","DOI":"10.1016\/j.jddst.2021.102972","volume":"67","author":"A Mushtaq","year":"2022","unstructured":"Mushtaq, A. et al. Fluconazole-loaded thermosensitive system: In vitro release, pharmacokinetics and safety study. J. Drug Deliv. Sci. Technol. 67, 102972. https:\/\/doi.org\/10.1016\/j.jddst.2021.102972 (2022).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"63587_CR40","doi-asserted-by":"publisher","unstructured":"Liigand, J., Laaniste, A. & Kruve, A. pH effects on electrospray ionization efficiency. J. Am. Soc. Mass Spectrom. 28(3), 461. https:\/\/doi.org\/10.1007\/s13361-016-1563-1 (2017).","DOI":"10.1007\/s13361-016-1563-1"},{"key":"63587_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mineng.2016.04.015","volume":"94","author":"Y Shen","year":"2016","unstructured":"Shen, Y. et al. Development of Greenness Index as an evaluation tool to assess reagents: Evaluation based on SDS (Safety Data Sheet) information. Miner. Eng. 94, 1\u20139. https:\/\/doi.org\/10.1016\/j.mineng.2016.04.015 (2016).","journal-title":"Miner. Eng."},{"key":"63587_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-026-06603-1","author":"F Vasileiou","year":"2026","unstructured":"Vasileiou, F. et al. Development of a capsule phase microextraction (CPME) protocol for the determination of four tetracyclines in human urine prior to HPLC\u2013DAD analysis. Anal. Bioanal. Chem. https:\/\/doi.org\/10.1007\/s00216-026-06603-1 (2026).","journal-title":"Anal. Bioanal. Chem."},{"issue":"12","key":"63587_CR43","doi-asserted-by":"publisher","first-page":"e70157","DOI":"10.1002\/sscp.70157","volume":"8","author":"P Prajapati","year":"2025","unstructured":"Prajapati, P. et al. Integrated approach of risk-based quality by design and multicolored sustainable analytical chemistry to stability-indicating chromatographic method for concurrent analysis of sitagliptin and glimepiride. Sep. Sci. PLUS. 8 (12), e70157. https:\/\/doi.org\/10.1002\/sscp.70157 (2025).","journal-title":"Sep. Sci. PLUS"},{"issue":"24","key":"63587_CR44","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1039\/d5an01052g","volume":"150","author":"S Nakka","year":"2025","unstructured":"Nakka, S., Marisetti, V. M. & Manabolu Surya, S. B. A sustainable and novel LC-TQ-MS\/MS method for quantifying mutagenic Ketoconazole-NDSRIs aligned with green and white analytical chemistry principles. Analyst 150 (24), 5457\u20135472. https:\/\/doi.org\/10.1039\/d5an01052g (2025).","journal-title":"Analyst"},{"issue":"17","key":"63587_CR45","doi-asserted-by":"publisher","first-page":"17836","DOI":"10.1021\/acsomega.5c00569","volume":"10","author":"S Levent","year":"2025","unstructured":"Levent, S. et al. LC-MS\/MS and LC-PDA methods for robust determination of glycerol phenylbutyrate in biological fluids and high-resolution mass spectrometric identification of forced degradation product and its whiteness. ACS Omega. 10 (17), 17836\u201317846. https:\/\/doi.org\/10.1021\/acsomega.5c00569 (2025).","journal-title":"ACS Omega"},{"issue":"1","key":"63587_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13065-023-01015-z","volume":"17","author":"HM Marzouk","year":"2023","unstructured":"Marzouk, H. M. et al. Sustainable chromatographic quantitation of multi-antihypertensive medications: application on diverse combinations containing hydrochlorothiazide along with LC\u2013MS\/MS profiling of potential impurities: greenness and whiteness evaluation. BMC Chem. 17 (1), 101. https:\/\/doi.org\/10.1186\/s13065-023-01015-z (2023).","journal-title":"BMC Chem."},{"issue":"22","key":"63587_CR47","doi-asserted-by":"publisher","first-page":"13896","DOI":"10.1039\/d2ra00966h","volume":"12","author":"MY Fares","year":"2022","unstructured":"Fares, M. Y. et al. Quality by design approach for green HPLC method development for simultaneous analysis of two thalassemia drugs in biological fluid with pharmacokinetic study. RSC Adv. 12 (22), 13896\u201313916. https:\/\/doi.org\/10.1039\/d2ra00966h (2022).","journal-title":"RSC Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63587-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63587-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63587-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:14:54Z","timestamp":1785521694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63587-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["63587"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-63587-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"21 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of this study was approved by the Ethics Committee of Faculty of Pharmacy, MSA University (Ref. No.: A7\/Ec7\/2022F). The MSA Ethics Committee waived the requirement for informed consent from all participants or their legal guardians, including consent for the use of plasma samples.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23496"}}